Cognitive remediation therapy for post-acute persistent cognitive deficits in COVID-19 survivors: A proof-of-concept study

Cognitive impairments figure prominently in COVID-19 survivors. Cognitive remediation therapy (CRT) improves functional outcomes reducing long-term cognitive deficits in several neurological and psychiatric conditions. Our case-control study investigates the efficacy of a CRT programme administered...

Full description

Saved in:
Bibliographic Details
Published inNeuropsychological rehabilitation Vol. 33; no. 7; pp. 1207 - 1224
Main Authors Palladini, Mariagrazia, Bravi, Beatrice, Colombo, Federica, Caselani, Elisa, Di Pasquasio, Camilla, D'Orsi, Greta, Rovere-Querini, Patrizia, Poletti, Sara, Benedetti, Francesco, Mazza, Mario Gennaro
Format Journal Article
LanguageEnglish
Published England Routledge 09.08.2023
Taylor & Francis Ltd
Taylor & Francis (Routledge)
Subjects
Civil Engineering
Cognitive ability
Cognitive functioning
Cognitive impairment
Cognitive remediation therapy
Coordination
COVID-19
Depression
Efficacy
Engineering Sciences
Executive function
Fluency
Functional impairment
Human health and pathology
Life Sciences
Mental depression
Neurological diseases
Psychiatrics and mental health
Quality of life
Rehabilitation
SARS-CoV-2
Short term memory
Survivor
Depression
SARS-CoV-2
Covid-19
Cognitive remediation therapy
Cognitive impairment
Online AccessGet full text

Cover

Abstract Cognitive impairments figure prominently in COVID-19 survivors. Cognitive remediation therapy (CRT) improves functional outcomes reducing long-term cognitive deficits in several neurological and psychiatric conditions. Our case-control study investigates the efficacy of a CRT programme administered to COVID-19 survivors in the post-acute phase of the illness. Seventy-three COVID-19 survivors presenting cognitive impairments at one-month follow-up were enrolled. Among them, 15 patients were treated with a two-month CRT programme, and 30 non-treated patients were matched conditional to their baseline cognitive functioning. Cognitive functions were assessed before and after treatment. Depression and quality of life were also evaluated. Mixed model ANOVA revealed a significant effect over time of the CRT programme on global cognitive functioning (F = 4.56, p = 0.039), while no significant effect was observed in the untreated group. We observed a significant effect of the improvement in verbal fluency (χ 2  = 7.20, p = 0.007) and executive functions (χ 2  = 13.63, p < 0.001) on quality of life. A positive significant correlation was found between depressive symptomatology and verbal fluency (r = −0.35), working memory (r = −0.44), psychomotor coordination (r  = −0.42), and executive functions (r  = −0.33). Our results could pave the way to a plausible innovative treatment targeting cognitive impairments and ameliorating the quality of life of COVID-19 survivors.
AbstractList Cognitive impairments figure prominently in COVID-19 survivors. Cognitive remediation therapy (CRT) improves functional outcomes reducing long-term cognitive deficits in several neurological and psychiatric conditions. Our case-control study investigates the efficacy of a CRT programme administered to COVID-19 survivors in the post-acute phase of the illness. Seventy-three COVID-19 survivors presenting cognitive impairments at one-month follow-up were enrolled. Among them, 15 patients were treated with a two-month CRT programme, and 30 non-treated patients were matched conditional to their baseline cognitive functioning. Cognitive functions were assessed before and after treatment. Depression and quality of life were also evaluated. Mixed model ANOVA revealed a significant effect over time of the CRT programme on global cognitive functioning (F = 4.56, p = 0.039), while no significant effect was observed in the untreated group. We observed a significant effect of the improvement in verbal fluency (χ2 = 7.20, p = 0.007) and executive functions (χ2 = 13.63, p < 0.001) on quality of life. A positive significant correlation was found between depressive symptomatology and verbal fluency (r = −0.35), working memory (r = −0.44), psychomotor coordination (r  = −0.42), and executive functions (r  = −0.33). Our results could pave the way to a plausible innovative treatment targeting cognitive impairments and ameliorating the quality of life of COVID-19 survivors.
Cognitive impairments figure prominently in COVID-19 survivors. Cognitive remediation therapy (CRT) improves functional outcomes reducing long-term cognitive deficits in several neurological and psychiatric conditions. Our case-control study investigates the efficacy of a CRT programme administered to COVID-19 survivors in the post-acute phase of the illness. Seventy-three COVID-19 survivors presenting cognitive impairments at one-month follow-up were enrolled. Among them, 15 patients were treated with a two-month CRT programme, and 30 non-treated patients were matched conditional to their baseline cognitive functioning. Cognitive functions were assessed before and after treatment. Depression and quality of life were also evaluated. Mixed model ANOVA revealed a significant effect over time of the CRT programme on global cognitive functioning (  = 4.56,  = 0.039), while no significant effect was observed in the untreated group. We observed a significant effect of the improvement in verbal fluency (  = 7.20,  = 0.007) and executive functions (  = 13.63,  < 0.001) on quality of life. A positive significant correlation was found between depressive symptomatology and verbal fluency (  = -0.35), working memory (  = -0.44), psychomotor coordination (  = -0.42), and executive functions (  = -0.33). Our results could pave the way to a plausible innovative treatment targeting cognitive impairments and ameliorating the quality of life of COVID-19 survivors.
Cognitive impairments figure prominently in COVID-19 survivors. Cognitive remediation therapy (CRT) improves functional outcomes reducing long-term cognitive deficits in several neurological and psychiatric conditions. Our case-control study investigates the efficacy of a CRT programme administered to COVID-19 survivors in the post-acute phase of the illness. Seventy-three COVID-19 survivors presenting cognitive impairments at one-month follow-up were enrolled. Among them, 15 patients were treated with a two-month CRT programme, and 30 non-treated patients were matched conditional to their baseline cognitive functioning. Cognitive functions were assessed before and after treatment. Depression and quality of life were also evaluated. Mixed model ANOVA revealed a significant effect over time of the CRT programme on global cognitive functioning (F = 4.56, p = 0.039), while no significant effect was observed in the untreated group. We observed a significant effect of the improvement in verbal fluency (χ 2  = 7.20, p = 0.007) and executive functions (χ 2  = 13.63, p < 0.001) on quality of life. A positive significant correlation was found between depressive symptomatology and verbal fluency (r = −0.35), working memory (r = −0.44), psychomotor coordination (r  = −0.42), and executive functions (r  = −0.33). Our results could pave the way to a plausible innovative treatment targeting cognitive impairments and ameliorating the quality of life of COVID-19 survivors.
Cognitive impairments figure prominently in COVID-19 survivors. Cognitive remediation therapy (CRT) improves functional outcomes reducing long-term cognitive deficits in several neurological and psychiatric conditions. Our case-control study investigates the efficacy of a CRT programme administered to COVID-19 survivors in the post-acute phase of the illness. Seventy-three COVID-19 survivors presenting cognitive impairments at one-month follow-up were enrolled. Among them, 15 patients were treated with a two-month CRT programme, and 30 non-treated patients were matched conditional to their baseline cognitive functioning. Cognitive functions were assessed before and after treatment. Depression and quality of life were also evaluated. Mixed model ANOVA revealed a significant effect over time of the CRT programme on global cognitive functioning (F = 4.56, p = 0.039), while no significant effect was observed in the untreated group. We observed a significant effect of the improvement in verbal fluency (χ2 = 7.20, p = 0.007) and executive functions (χ2 = 13.63, p < 0.001) on quality of life. A positive significant correlation was found between depressive symptomatology and verbal fluency (r = -0.35), working memory (r = -0.44), psychomotor coordination (r = -0.42), and executive functions (r = -0.33). Our results could pave the way to a plausible innovative treatment targeting cognitive impairments and ameliorating the quality of life of COVID-19 survivors.
Author Palladini, Mariagrazia
Mazza, Mario Gennaro
Poletti, Sara
Colombo, Federica
Di Pasquasio, Camilla
Caselani, Elisa
Benedetti, Francesco
Rovere-Querini, Patrizia
D'Orsi, Greta
Bravi, Beatrice
Author_xml – sequence: 1
  givenname: Mariagrazia
  orcidid: 0000-0003-4616-4185
  surname: Palladini
  fullname: Palladini, Mariagrazia
  email: palladini.mariagrazia@hsr.it
  organization: University Vita-Salute San Raffaele
– sequence: 2
  givenname: Beatrice
  orcidid: 0000-0003-2568-4181
  surname: Bravi
  fullname: Bravi, Beatrice
  organization: University Vita-Salute San Raffaele
– sequence: 3
  givenname: Federica
  surname: Colombo
  fullname: Colombo, Federica
  organization: University Vita-Salute San Raffaele
– sequence: 4
  givenname: Elisa
  surname: Caselani
  fullname: Caselani, Elisa
  organization: IRCCS Scientific Institute Ospedale San Raffaele
– sequence: 5
  givenname: Camilla
  surname: Di Pasquasio
  fullname: Di Pasquasio, Camilla
  organization: IRCCS Scientific Institute Ospedale San Raffaele
– sequence: 6
  givenname: Greta
  surname: D'Orsi
  fullname: D'Orsi, Greta
  organization: IRCCS Scientific Institute Ospedale San Raffaele
– sequence: 7
  givenname: Patrizia
  orcidid: 0000-0003-2615-3649
  surname: Rovere-Querini
  fullname: Rovere-Querini, Patrizia
  organization: IRCCS San Raffaele Scientific Institute
– sequence: 8
  givenname: Sara
  surname: Poletti
  fullname: Poletti, Sara
  organization: Vita-Salute San Raffaele University
– sequence: 9
  givenname: Francesco
  orcidid: 0000-0003-4949-856X
  surname: Benedetti
  fullname: Benedetti, Francesco
  organization: Vita-Salute San Raffaele University
– sequence: 10
  givenname: Mario Gennaro
  surname: Mazza
  fullname: Mazza, Mario Gennaro
  organization: University Vita-Salute San Raffaele
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35583357$$D View this record in MEDLINE/PubMed
https://hal.science/hal-04735294$$DView record in HAL
BookMark eNp9kU9rFDEYh4NU7Lb6EZSAF3uYmv_JeOqyVVtY6EW9hmwmY1NmkzHJrKyf3gy73YMHIbyB8PzevC_PBTgLMTgA3mJ0jZFCH1ErEEEYXxNESC2SIyxegAVmgjVItOwMLGammaFzcJHzE0JYISZegXPKuaKUywX4s4o_gy9-52ByW9d5U3wMsDy6ZMY97GOCY8ylMXYqDo4uZZ-LCwXaU65zvbe-ZOgDXD38uL9tcAvzlHZ-F1P-BJdwTDH2TT02BuvGAnOZuv1r8LI3Q3Zvjvcl-P7l87fVXbN--Hq_Wq4by4gqjbWMtr1hBHNmHVFKMGVl5zaC4tYJg5yUWCpqGZOut6anhHPZbVqMWWtlSy_B1aHvoxn0mPzWpL2Oxuu75VrPb4hJyknLdriyHw5sHfnX5HLRW5-tGwYTXJyyJkIIzhFFrKLv_0Gf4pRC3UQTxbBQTChZKX6gbIo5J9efJsBIzyL1s0g9i9RHkTX37th92lQtp9SzuQrcHAAfqqSt-R3T0Oli9kNMfTLB-qzp___4C2FOrXI
CitedBy_id crossref_primary_10_1002_acn3_51952
crossref_primary_10_1038_s41420_023_01512_z
crossref_primary_10_3138_ptc_2023_0075
crossref_primary_10_1007_s00406_023_01662_2
crossref_primary_10_1024_1016_264X_a000376
crossref_primary_10_3389_fphar_2024_1338235
crossref_primary_10_1186_s12883_023_03346_9
crossref_primary_10_1097_YIC_0000000000000537
Cites_doi 10.1007/s11481-020-09966-z
10.1016/S2215-0366(20)30287-X
10.1093/braincomms/fcaa072
10.1016/j.bbi.2021.02.021
10.1017/S0033291713002535
10.1016/S1474-4422(20)30221-0
10.1016/j.schres.2003.09.011
10.1007/s10072-008-0866-9
10.18637/jss.v042.i08
10.1038/s41572-020-0201-1
10.1002/da.22063
10.1056/NEJMc2008597
10.1016/j.cytogfr.2020.05.003
10.2139/ssrn.3820561
10.1186/s13054-019-2626-z
10.1016/j.jpsychires.2020.06.022
10.1017/S1355617720000120
10.1002/pds.2188
10.1016/S2213-2600(18)30062-6
10.1056/NEJMoa1301372
10.1016/j.bbi.2020.07.037
10.1080/13854046.2020.1803408
10.1007/s11065-013-9230-9
10.1111/joim.13262
10.1513/AnnalsATS.201709-744RL
10.1016/S2215-0366(21)00084-5
10.1164/rccm.200406-763OC
10.1080/02699050500488199
10.1093/pan/mpl013
10.1016/j.eurpsy.2004.06.023
10.1017/S003329171900240X
10.1038/nrneurol.2014.181
10.1016/j.euroneuro.2021.03.019
10.1093/braincomms/fcaa205
10.3389/fpsyt.2020.621773
10.1111/j.1468-1331.2005.01330.x
10.1007/978-94-007-0753-5_2641
10.1016/j.psychres.2008.06.027
10.1177/0004867413502090
10.1016/j.bbih.2020.100163
10.1080/13651501.2020.1791345
10.1093/med:psych/9780199395224.001.0001
10.1126/science.368.6490.455
10.1016/j.mam.2015.06.003
10.1038/s41591-021-01283-z
10.1001/archpsyc.1965.01720310065008
10.1016/j.jana.2012.01.005
10.1016/S0140-6736(20)32656-8
10.3390/cells9112360
10.1007/978-1-4899-3242-6
10.1016/j.bbi.2020.05.062
10.1136/jnnp-2020-325173
10.1023/B:QURE.0000018486.91360.00
10.1097/01.CCM.0000059996.30263.94
10.1038/s41386-021-00978-8
10.1101/2020.10.20.20215863
10.1111/eip.12289
ContentType Journal Article
Copyright 2022 Informa UK Limited, trading as Taylor & Francis Group 2022
2022 Informa UK Limited, trading as Taylor & Francis Group
Distributed under a Creative Commons Attribution 4.0 International License
Copyright_xml – notice: 2022 Informa UK Limited, trading as Taylor & Francis Group 2022
– notice: 2022 Informa UK Limited, trading as Taylor & Francis Group
– notice: Distributed under a Creative Commons Attribution 4.0 International License
DBID NPM
AAYXX
CITATION
7QJ
7TK
7TS
K9.
NAPCQ
7X8
1XC
DOI 10.1080/09602011.2022.2075016
DatabaseName PubMed
CrossRef
Applied Social Sciences Index & Abstracts (ASSIA)
Neurosciences Abstracts
Physical Education Index
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
Hyper Article en Ligne (HAL)
DatabaseTitle PubMed
CrossRef
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Applied Social Sciences Index and Abstracts (ASSIA)
Neurosciences Abstracts
Physical Education Index
MEDLINE - Academic
DatabaseTitleList ProQuest Health & Medical Complete (Alumni)
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1464-0694
EndPage 1224
ExternalDocumentID oai_HAL_hal_04735294v1
10_1080_09602011_2022_2075016
35583357
2075016
Genre Articles
Journal Article
GroupedDBID ---
.7I
.QK
0BK
0R~
123
29N
36B
4.4
5VS
AAAVI
AAGZJ
AAMFJ
AAMIU
AAPUL
AATTQ
AAWTL
AAZMC
ABBKH
ABCCY
ABDBF
ABFIM
ABIVO
ABJVF
ABLIJ
ABPEM
ABPTK
ABPTX
ABQHQ
ABRYG
ABSSG
ABTAI
ABXUL
ABXYU
ABZLS
ACGEJ
ACGFO
ACGFS
ACLSK
ACPRK
ACTIO
ACTOA
ADAHI
ADCVX
ADXPE
AECIN
AEGXH
AEGYZ
AEISY
AEKEX
AENEX
AEOZL
AEPSL
AEYOC
AEZRU
AFHDM
AFOLD
AFWLO
AGDLA
AGMYJ
AGRBW
AHMBA
AIAGR
AIJEM
AJWEG
AKBVH
ALMA_UNASSIGNED_HOLDINGS
ALQZU
AVBZW
AWYRJ
BEJHT
BLEHA
BMOTO
BOHLJ
CCCUG
CQ1
CS3
DKSSO
DU5
DXH
EAP
EBS
EPS
ESX
E~B
E~C
F5P
FEDTE
FMBMU
FUNRP
FXNIP
G-F
GTTXZ
HF~
HZ~
IPNFZ
J.O
KDLKA
KRBQP
KSSTO
KWAYT
KYCEM
LGLTD
LJTGL
M4Z
NA5
NW-
O9-
P2P
PQEST
PQQKQ
RIG
RNANH
ROSJB
RSYQP
S-F
STATR
TEH
TFH
TFL
TFW
TNTFI
TRJHH
UT5
UT9
V1K
VAE
~01
~S~
.GJ
07M
1TA
2QV
4B3
53G
ABJNI
ABTAH
ABVXC
ABWZE
ACIKQ
ACPKE
ACRBO
ADEWX
ADIUE
ADKVQ
ADXAZ
AEXSR
AHDZW
AIXGP
ALLRG
C5A
CAG
CBZAQ
CKOZC
COF
C~T
DGFLZ
DGXZK
EBD
EFRLQ
EGDCR
EJD
EMK
EPL
H13
HVGLF
JLMOS
L7Y
MLAFT
NPM
QZZOY
RBICI
TBH
TBQAZ
TUROJ
UA1
ZY4
AAYXX
CITATION
7QJ
7TK
7TS
K9.
NAPCQ
7X8
1XC
ID FETCH-LOGICAL-c428t-cc439fa42154ce288648c7deb6319e6a0e771783c447efcaf32557db91149c793
ISSN 0960-2011
IngestDate Wed Oct 16 06:44:28 EDT 2024
Fri Oct 25 23:25:26 EDT 2024
Thu Oct 10 21:53:45 EDT 2024
Fri Aug 23 03:27:36 EDT 2024
Wed Oct 16 00:39:05 EDT 2024
Thu Aug 10 13:47:10 EDT 2023
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords Depression
SARS-CoV-2
Covid-19
Cognitive remediation therapy
Cognitive impairment
Language English
License Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c428t-cc439fa42154ce288648c7deb6319e6a0e771783c447efcaf32557db91149c793
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-2568-4181
0000-0003-4949-856X
0000-0003-2615-3649
0000-0003-4616-4185
PMID 35583357
PQID 2841684687
PQPubID 436415
PageCount 18
ParticipantIDs pubmed_primary_35583357
crossref_primary_10_1080_09602011_2022_2075016
proquest_journals_2841684687
proquest_miscellaneous_2666550304
hal_primary_oai_HAL_hal_04735294v1
informaworld_taylorfrancis_310_1080_09602011_2022_2075016
PublicationCentury 2000
PublicationDate 2023-08-09
PublicationDateYYYYMMDD 2023-08-09
PublicationDate_xml – month: 08
  year: 2023
  text: 2023-08-09
  day: 09
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Hove
PublicationTitle Neuropsychological rehabilitation
PublicationTitleAlternate Neuropsychol Rehabil
PublicationYear 2023
Publisher Routledge
Taylor & Francis Ltd
Taylor & Francis (Routledge)
Publisher_xml – name: Routledge
– name: Taylor & Francis Ltd
– name: Taylor & Francis (Routledge)
References CIT0031
CIT0034
Kim E. J. (CIT0030) 2018; 9
CIT0033
Taribagil P. (CIT0056) 2021; 14
CIT0036
CIT0035
CIT0038
CIT0037
CIT0039
CIT0041
CIT0043
CIT0042
CIT0001
CIT0045
Poletti S. (CIT0044) 2021
CIT0003
CIT0047
CIT0002
CIT0046
CIT0005
CIT0049
CIT0004
CIT0048
CIT0007
WHO (CIT0059) 2021
CIT0006
CIT0009
CIT0050
CIT0052
CIT0051
CIT0010
CIT0054
CIT0053
CIT0012
CIT0011
Mantovani E. (CIT0032) 2020; 11
CIT0055
Birnboim S. (CIT0008) 2004; 22
CIT0014
CIT0058
CIT0013
CIT0057
CIT0016
CIT0015
CIT0018
CIT0017
CIT0019
CIT0061
CIT0060
CIT0063
CIT0062
CIT0021
CIT0065
CIT0020
CIT0064
CIT0023
CIT0022
CIT0025
CIT0024
CIT0027
CIT0026
CIT0029
Muthukrishnan H. (CIT0040) 2020; 3
CIT0028
References_xml – ident: CIT0007
  doi: 10.1007/s11481-020-09966-z
– ident: CIT0058
  doi: 10.1016/S2215-0366(20)30287-X
– ident: CIT0031
  doi: 10.1093/braincomms/fcaa072
– ident: CIT0034
  doi: 10.1016/j.bbi.2021.02.021
– ident: CIT0047
  doi: 10.1017/S0033291713002535
– ident: CIT0015
  doi: 10.1016/S1474-4422(20)30221-0
– ident: CIT0029
  doi: 10.1016/j.schres.2003.09.011
– volume: 3
  start-page: 1
  year: 2020
  ident: CIT0040
  publication-title: The Journal of Science and Medicine
  contributor:
    fullname: Muthukrishnan H.
– ident: CIT0004
  doi: 10.1007/s10072-008-0866-9
– ident: CIT0019
  doi: 10.18637/jss.v042.i08
– ident: CIT0023
  doi: 10.1038/s41572-020-0201-1
– ident: CIT0036
  doi: 10.1002/da.22063
– ident: CIT0018
  doi: 10.1056/NEJMc2008597
– ident: CIT0012
  doi: 10.1016/j.cytogfr.2020.05.003
– ident: CIT0014
  doi: 10.2139/ssrn.3820561
– volume: 22
  start-page: 8
  issue: 4
  year: 2004
  ident: CIT0008
  publication-title: Journal Cognitive Rehabilitation
  contributor:
    fullname: Birnboim S.
– ident: CIT0050
  doi: 10.1186/s13054-019-2626-z
– ident: CIT0064
  doi: 10.1016/j.jpsychires.2020.06.022
– ident: CIT0028
  doi: 10.1017/S1355617720000120
– ident: CIT0006
  doi: 10.1002/pds.2188
– ident: CIT0016
  doi: 10.1016/S2213-2600(18)30062-6
– ident: CIT0043
  doi: 10.1056/NEJMoa1301372
– ident: CIT0033
  doi: 10.1016/j.bbi.2020.07.037
– ident: CIT0046
  doi: 10.1080/13854046.2020.1803408
– ident: CIT0025
  doi: 10.1007/s11065-013-9230-9
– ident: CIT0038
  doi: 10.1111/joim.13262
– ident: CIT0060
  doi: 10.1513/AnnalsATS.201709-744RL
– ident: CIT0055
  doi: 10.1016/S2215-0366(21)00084-5
– volume: 9
  issue: 461
  year: 2018
  ident: CIT0030
  publication-title: Frontiers in Psychiatry
  contributor:
    fullname: Kim E. J.
– ident: CIT0022
  doi: 10.1164/rccm.200406-763OC
– ident: CIT0021
  doi: 10.1080/02699050500488199
– ident: CIT0020
  doi: 10.1093/pan/mpl013
– ident: CIT0053
  doi: 10.1016/j.eurpsy.2004.06.023
– volume: 11
  issue: 926
  year: 2020
  ident: CIT0032
  publication-title: Frontiers in Neurology
  contributor:
    fullname: Mantovani E.
– ident: CIT0051
  doi: 10.1017/S003329171900240X
– ident: CIT0049
  doi: 10.1038/nrneurol.2014.181
– ident: CIT0039
  doi: 10.1016/j.euroneuro.2021.03.019
– ident: CIT0061
  doi: 10.1093/braincomms/fcaa205
– ident: CIT0003
  doi: 10.3389/fpsyt.2020.621773
– ident: CIT0010
  doi: 10.1111/j.1468-1331.2005.01330.x
– ident: CIT0052
  doi: 10.1007/978-94-007-0753-5_2641
– ident: CIT0011
  doi: 10.1016/j.psychres.2008.06.027
– ident: CIT0045
  doi: 10.1177/0004867413502090
– ident: CIT0062
– ident: CIT0002
  doi: 10.1016/j.bbih.2020.100163
– ident: CIT0042
  doi: 10.1080/13651501.2020.1791345
– ident: CIT0037
  doi: 10.1093/med:psych/9780199395224.001.0001
– ident: CIT0013
  doi: 10.1126/science.368.6490.455
– volume: 14
  issue: 4
  year: 2021
  ident: CIT0056
  publication-title: BMJ Case Reports CP
  contributor:
    fullname: Taribagil P.
– volume-title: COVID-19 Dashboard
  year: 2021
  ident: CIT0059
  contributor:
    fullname: WHO
– ident: CIT0048
  doi: 10.1016/j.mam.2015.06.003
– ident: CIT0041
  doi: 10.1038/s41591-021-01283-z
– ident: CIT0065
  doi: 10.1001/archpsyc.1965.01720310065008
– start-page: 1
  year: 2021
  ident: CIT0044
  publication-title: European Archives of Psychiatry and Clinical Neuroscience
  contributor:
    fullname: Poletti S.
– ident: CIT0057
  doi: 10.1016/j.jana.2012.01.005
– ident: CIT0024
  doi: 10.1016/S0140-6736(20)32656-8
– ident: CIT0001
  doi: 10.3390/cells9112360
– ident: CIT0035
  doi: 10.1007/978-1-4899-3242-6
– ident: CIT0063
  doi: 10.1016/j.bbi.2020.05.062
– ident: CIT0005
  doi: 10.1136/jnnp-2020-325173
– ident: CIT0054
  doi: 10.1023/B:QURE.0000018486.91360.00
– ident: CIT0026
  doi: 10.1097/01.CCM.0000059996.30263.94
– ident: CIT0027
  doi: 10.1038/s41386-021-00978-8
– ident: CIT0017
  doi: 10.1101/2020.10.20.20215863
– ident: CIT0009
  doi: 10.1111/eip.12289
SSID ssj0018046
Score 2.4567235
Snippet Cognitive impairments figure prominently in COVID-19 survivors. Cognitive remediation therapy (CRT) improves functional outcomes reducing long-term cognitive...
SourceID hal
proquest
crossref
pubmed
informaworld
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 1207
SubjectTerms Civil Engineering
Cognitive ability
Cognitive functioning
Cognitive impairment
Cognitive remediation therapy
Coordination
COVID-19
Depression
Efficacy
Engineering Sciences
Executive function
Fluency
Functional impairment
Human health and pathology
Life Sciences
Mental depression
Neurological diseases
Psychiatrics and mental health
Quality of life
Rehabilitation
SARS-CoV-2
Short term memory
Survivor
Title Cognitive remediation therapy for post-acute persistent cognitive deficits in COVID-19 survivors: A proof-of-concept study
URI https://www.tandfonline.com/doi/abs/10.1080/09602011.2022.2075016
https://www.ncbi.nlm.nih.gov/pubmed/35583357
https://www.proquest.com/docview/2841684687
https://search.proquest.com/docview/2666550304
https://hal.science/hal-04735294
Volume 33
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELa6uxLignhTWJBB3Kqskth5lFvpblVQd_fSQsXFShxnKYKkatIe-jf4w8zETpqiIhakKqqS1In8fR3PjOdByNvUA9Bt5lpOX6UWB5PBCpPYtWBxsxXDfZkUE4Uvr_zxjH-ce_NO52cramldxmdyezCv5H9QhXOAK2bJ_gOyzaBwAr4DvnAEhOF4K4yHTewPevkSPcs9nVKlAzGXeVFakcRggCV6xgDTrOztYoYShRUkyioodnj96cM5zGavWIP82OSrQqetg4zNUws-Uqc4tkrSfqtrP6FPf0-UrvYqgO82qoB1sFouTJrQIrpZRdtFyykQbapr71XVOqBh3RAG_hFXbt0Rlr9oRxjBOvxdd6bCILUiajsyXFaF0WlxqbTw5T63MBG3LZ11mQzDwqAlah1Xt8s1yzbuEB5cEkwMJVhqVb1WeDLm34Gi5BwowX11LUazyURML-bTI3LiApFBbJ4MxudfPjebU6HN_ToZDMu0Hxp6T805-loF2bZL4f7ZoKkUm-l9cs9YJHSg6fWAdFT2kNy5NDEXj8i2YRltsYwallF4GN2xjO5YRhuW0ZpldJHRmmW0Ydk7OqC_c4xWHHtMZqOL6XBsmY4dlgQztrSkBP02jTjokVwqNwx9HsogUbEPkl75ka2CwAlCJjkPVCqjlIFFGyQxrLi8L2Gyn5DjLM_UM0J5FHI3ScA-YCn3eBIyW9rMY54CpTiJZZec1RMslrowi3DqercGEYGICINIl7wBGJp7saz6eDAReM7G_ttun2-cLum3URJl5TZLdY8bwf7ygNMaUmGERCFc3NYHHT8MuuR1cxlEOO7LRZnK13CP7_uehzEKXfJUU6F5Tex-wJgXPL_Fr1-Qu7v_1Sk5Lldr9RJU5jJ-ZSj8C4V1wXA
link.rule.ids 230,315,783,787,888,27936,27937,59983,60772
linkProvider Library Specific Holdings
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7RVgIuvB-BAgZx9ZKNnRe31UKVlt0ioS3qzUocWyCkZNUkleivZyZOogWp4lApp7ztGY_n88x8BnhvQxS6LwI-T43lEiEDT8oi4Di5-UZQXMZSofD6NMrO5Ml5eL5TC0NplYShrSOK6G01DW5ajB5T4j6Q292TbyJyp2IqnPXm0R4chIgdUNcPNt9OsmyKJSS-K9fBhzg9NdbxXPeiv2aovR99fuQui-n1vmg_Jx3dBz22xqWi_Jp1bTHTV_8QPd6suQ_g3uCysoXTsYdwy1SP4PZ6CMo_hqvlmILEaLGxdMJmrrLrN8MmsW3dtDzXXWvYlhboULWqlk2pS6w0RGTRNuxnxZZfvx9_QqGypkMzdllfNB_ZgmEba8vx0K7OkvW8uE_g7OjzZpnxYUsHrhHntFxrdIBsLtHRkNoESRLJRMelKSI0BSbKfRMjvkyEljI2VudWIOSJywJNskw1qtVT2K_qyjwHJvNEBmWJDqSwMpRlInzti1CEBr2mstAezEYxqq1j7lDzkRB16FFFPaqGHvXgHQp7upd4t7PFStE5nzZoDlJ5Ofcg3dUF1fbrKtZtgqLEfz5wOCqOGixFowKK-6ITmMQevJ0u4xinwE1embrDexBjIpIUvvTgmVO46TeJHl-IMH5xgx97A3eyzXqlVsenX17CXbwk-hzH9BD224vOvEK_qy1eDwPrD_pQHS8
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7RrVRxoTxLoIBBXL1kYydxuK22rNLSFoRaxM1K_BAIKVk1SaX21zOOk6ggVRwq5ZS3PePxN56ZzwDvbYxCD1lEF5mxlKPLQIUuI4qTW2iYi8tYVyh8cprk5_zoRzxmEzZDWqXzoa0niuhttRvcG23HjLgPDnX33JvouLtaKpz0FskWbCchQsUZbJ99O8rzKZQgQl-tgw9R99RYxnPbi_6aoLZ-9umRN0lMb4ei_ZS03oVybIzPRPk979pyrq7_4Xm8U2sfwoMBsJKl17BHcM9Uj2HnZAjJP4Hr1ZiARNxSo_aiJr6u64pgi8imblpaqK41ZOOW51CxqpZMiUtEG0dj0TbkV0VWX74fHqBISdOhEbusL5qPZEmwibWleChfZUl6VtyncL7-dLbK6bChA1Xo5bRUKYQ_tuAIM7gykRAJFyrVpkzQEJikCE2K3qVgivPUWFVYhg5Pqks0yDxTqFTPYFbVlXkOhBeCR1ojfGSWx1wLFqqQxSw2iJl0qQKYj1KUG8_bIRcjHerQo9L1qBx6NIB3KOvpXse6nS-PpTsXuu2Zo4xfLgLIbqqCbPtVFeu3QJHsPx_YH_VGDnaikZGL-iIEFGkAb6fLOMJd2KaoTN3hPehhoh_JQh7Ante36TcdOT5jcfriDj_2Bna-Hqzl8eHp55dwH6-wPsEx24dZe9GZVwi62vL1MKz-AFOfG9M
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cognitive+remediation+therapy+for+post-acute+persistent+cognitive+deficits+in+COVID-19+survivors%3A+A+proof-of-concept+study&rft.jtitle=Neuropsychological+rehabilitation&rft.au=Palladini%2C+Mariagrazia&rft.au=Bravi%2C+Beatrice&rft.au=Colombo%2C+Federica&rft.au=Caselani%2C+Elisa&rft.date=2023-08-09&rft.eissn=1464-0694&rft.volume=33&rft.issue=7&rft.spage=1207&rft.epage=1224&rft_id=info:doi/10.1080%2F09602011.2022.2075016&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0960-2011&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0960-2011&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0960-2011&client=summon